Healthtech startup Neurowyzr raises $2.1M in a seed round led by Jungle Ventures, Peak XV

Singapore-based healthtech startup Neurowyzr has raised an additional $2.1 million in an oversubscribed seed funding round co-led by Jungle Ventures and Peak XV, bringing its total funding amount to $3.3 million.

Neurowyzr, which addresses neurological challenges, says the current round of funding will accelerate its product development and regional expansion plans. The startup looks to grow its sales, marketing and software development teams. Additionally, a portion of the funds will be allocated towards market expansion across Southeast Asia and India, the startup said.

Founded in 2019 by neuroscientists Nav Vij and Pang Sze Yunn, Neurowyzr offers a digital platform that analyzes brain function and provides instant medical reports using a series of gamified puzzles.

"Brain decline is a potentially debilitating condition that strikes fear in many people and brings immense cost on families and societies. Neurowyzr aims to address unmet needs of people to protect their brain health. We are grateful for the trust that our investors have shown in us and are excited that the partnership will enable us to make brain health accessible and affordable," said Pang Sze Yunn, co-founder and CEO of Neurowyzr.

"Projected numbers tell a stark story for Asia: over the next two decades, more than 66 million individuals could face dementia, while Mild Cognitive Impairment could affect over 400 million. Neurowyzr is a direct response to this challenge. By assessing brain and mental health promptly, we're building a proactive defence against a potential epidemic. This Singapore-born solution carries a global impact," said Seemant Jauhari, Partner, Healthcare, Jungle Ventures.

Also Read:

• Yummy Plate offering meal services for schools raises $2M in a seed round